AR091582A1 - Vacunas atenuadas contra streptococcus suis y metodos de elaboracion y uso de las mismas - Google Patents

Vacunas atenuadas contra streptococcus suis y metodos de elaboracion y uso de las mismas

Info

Publication number
AR091582A1
AR091582A1 ARP130102272A AR091582A1 AR 091582 A1 AR091582 A1 AR 091582A1 AR P130102272 A ARP130102272 A AR P130102272A AR 091582 A1 AR091582 A1 AR 091582A1
Authority
AR
Argentina
Prior art keywords
suis
methods
attended
elaboration
vaccines
Prior art date
Application number
Other languages
English (en)
Inventor
R Simonson Randy
F Bey Russell
Kirubakaran Lawrence Paulraj
Reddy Sirigireddy Kamesh
A Mkeown Danielle
Original Assignee
Merial Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merial Ltd filed Critical Merial Ltd
Publication of AR091582A1 publication Critical patent/AR091582A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/09—Lactobacillales, e.g. aerococcus, enterococcus, lactobacillus, lactococcus, streptococcus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/09—Lactobacillales, e.g. aerococcus, enterococcus, lactobacillus, lactococcus, streptococcus
    • A61K39/092—Streptococcus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
    • A61K2039/522—Bacterial cells; Fungal cells; Protozoal cells avirulent or attenuated
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
    • A61K2039/541—Mucosal route
    • A61K2039/542—Mucosal route oral/gastrointestinal
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552—Veterinary vaccine

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Immunology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Microbiology (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • Virology (AREA)
  • Biomedical Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Biochemistry (AREA)
  • Rheumatology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Pulmonology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)

Abstract

Cepas de S. suis atenuadas que generan una respuesta inmune en animales por S. suis, composiciones que comprenden dichas cepas, métodos de vacunación contra S. suis y conjuntos de elementos para su uso con dichos métodos y composiciones. La presente provee además mutaciones inducidas por mutagénesis en genes de S. suis, que son de utilidad en la producción de cepas bacterianas de S. suis atenuadas.
ARP130102272 2012-06-27 2013-06-27 Vacunas atenuadas contra streptococcus suis y metodos de elaboracion y uso de las mismas AR091582A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US201261664935P 2012-06-27 2012-06-27

Publications (1)

Publication Number Publication Date
AR091582A1 true AR091582A1 (es) 2015-02-11

Family

ID=48782624

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP130102272 AR091582A1 (es) 2012-06-27 2013-06-27 Vacunas atenuadas contra streptococcus suis y metodos de elaboracion y uso de las mismas

Country Status (19)

Country Link
US (1) US9289484B2 (es)
EP (1) EP2866828B1 (es)
JP (1) JP6262728B2 (es)
KR (1) KR102126096B1 (es)
CN (1) CN104780935B (es)
AR (1) AR091582A1 (es)
AU (2) AU2013280718B2 (es)
BR (1) BR112014032636A2 (es)
CA (1) CA2877817A1 (es)
DK (1) DK2866828T3 (es)
EA (1) EA036764B1 (es)
ES (1) ES2662801T3 (es)
HK (1) HK1203834A1 (es)
MX (1) MX365879B (es)
MY (1) MY173796A (es)
NZ (1) NZ703701A (es)
PH (1) PH12014502855A1 (es)
PL (1) PL2866828T3 (es)
WO (1) WO2014004361A1 (es)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9132183B2 (en) * 2007-03-09 2015-09-15 Newport Laboratories Modified live (JMSO strain) Haemophilus parasuis vaccine
US10280199B2 (en) 2014-02-07 2019-05-07 Phibro Animal Health Corporation Coronavirus proteins and antigens
US10266579B2 (en) 2014-09-14 2019-04-23 Tel Hashomer Medical Research Infrastructure And Services Ltd. Synthetic somatostatin receptor ligands
CN105348373B (zh) * 2015-11-24 2019-01-11 武汉天种畜牧股份有限公司 猪链球菌血清3型的粘附性抗原ssust3_1962及其制备方法和应用
WO2017196318A1 (en) * 2016-05-11 2017-11-16 Phibro Animal Health Corporation A composition comprising antigens and a mucosal adjuvant and a method for using
US10279031B2 (en) 2016-05-11 2019-05-07 Phibro Animal Health Corporation Composition comprising antigens and a mucosal adjuvant and a method for using
JP7220502B2 (ja) * 2017-03-15 2023-02-10 ロンドン スクール オブ ハイジーン アンド トロピカル メディシン 全細胞ワクチン
CN110891598A (zh) * 2017-08-03 2020-03-17 英特维特国际股份有限公司 用于针对猪链球菌的保护的疫苗
AU2018325528A1 (en) * 2017-08-31 2020-04-16 Newport Laboratories, Inc. Streptococcus suis vaccines to protect against reproductive, nursery-age, and growing pig diseases and methods of making and use thereof
BR112020011593A2 (pt) * 2017-12-15 2020-12-08 Intervet International B.V. Uma vacina para proteção contra streptococcus suis
CN110327460A (zh) * 2019-06-05 2019-10-15 中国农业科学院哈尔滨兽医研究所（中国动物卫生与流行病学中心哈尔滨分中心） 猪链球菌病-副猪嗜血杆菌病二联亚单位疫苗及制备方法
CN112694988B (zh) * 2020-12-15 2022-12-06 武汉市农业科学院 一种鸡源猪链球菌弱毒株及其应用
CN115161333B (zh) * 2022-06-23 2023-08-25 中国农业科学院哈尔滨兽医研究所（中国动物卫生与流行病学中心哈尔滨分中心） 一种猪链球菌的反向筛选标记、含有该反向筛选标记的猪链球菌及其应用

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3529056A (en) * 1968-05-07 1970-09-15 American Home Prod Method of producing jowl abscess vaccine
US4708871A (en) 1983-03-08 1987-11-24 Commonwealth Serum Laboratories Commission Antigenically active amino acid sequences
AU4992197A (en) 1996-10-11 1998-05-11 Regents Of The University Of California, The Immunostimulatory polynucleotide/immunomodulatory molecule conjugates
US5980912A (en) 1997-03-25 1999-11-09 Zonagen, Inc. Chitosan induced immunopotentiation
US6455323B1 (en) * 1997-07-03 2002-09-24 Pharmacia & Upjohn Company Anti-bacterial methods and materials
US6379676B2 (en) * 1999-03-10 2002-04-30 Anitox Corporation Enhancing immune response in animals
TW200406372A (en) * 2002-03-08 2004-05-01 Schering Plough Ltd Novel florfenicol-type antibiotics
JP4500615B2 (ja) * 2004-07-14 2010-07-14 日生研株式会社 エリシペロトリックス属のその他の菌種である血清型１８由来の豚丹毒菌感染防御活性を有する新規ポリペプチドとその遺伝子および製法
EP1994047A2 (en) * 2006-02-17 2008-11-26 Novartis AG Purification and use of streptococcus pneumoniae pili and pilus proteins
CN102317439B (zh) * 2009-02-20 2015-11-25 澳大利亚家禽Crc有限公司 减毒活疫苗
KR101209964B1 (ko) * 2010-10-15 2012-12-07 주식회사 동방 돼지 다발성 장막염 예방용 백신 조성물 및 그 제조방법

Also Published As

Publication number Publication date
DK2866828T3 (en) 2018-01-15
MX2015000045A (es) 2015-03-05
AU2013280718A1 (en) 2015-02-12
BR112014032636A2 (pt) 2017-08-29
ES2662801T3 (es) 2018-04-09
EA201500054A1 (ru) 2015-06-30
EA036764B1 (ru) 2020-12-17
PH12014502855B1 (en) 2015-02-09
JP2015522282A (ja) 2015-08-06
CN104780935A (zh) 2015-07-15
KR102126096B1 (ko) 2020-06-23
MX365879B (es) 2019-06-18
EP2866828A1 (en) 2015-05-06
KR20150033692A (ko) 2015-04-01
AU2016222520A1 (en) 2016-09-22
WO2014004361A1 (en) 2014-01-03
AU2013280718B2 (en) 2016-06-09
EP2866828B1 (en) 2017-12-13
US20140004144A1 (en) 2014-01-02
JP6262728B2 (ja) 2018-01-17
PH12014502855A1 (en) 2015-02-09
AU2016222520B2 (en) 2018-03-22
CN104780935B (zh) 2018-01-02
MY173796A (en) 2020-02-24
HK1203834A1 (en) 2015-11-06
PL2866828T3 (pl) 2018-04-30
US9289484B2 (en) 2016-03-22
CA2877817A1 (en) 2014-01-03
NZ703701A (en) 2016-03-31

Similar Documents

Publication Publication Date Title
AR091582A1 (es) Vacunas atenuadas contra streptococcus suis y metodos de elaboracion y uso de las mismas
EA201990566A1 (ru) Композиции, содержащие бактериальные штаммы
MX2018004475A (es) Agentes biologicos y su uso en plantas.
WO2016033439A3 (en) Compositions and methods for the treating an inflammatory disease or disorder
AU2015296298A8 (en) Flagellin-based agents and uses including effective vaccination
MX2017008819A (es) Anticuerpos anti-cd47 y usos de los mismos.
TN2017000246A1 (en) Anti-c10orf54 antibodies and uses thereof
MX2019002979A (es) Formulaciones de anticuerpos.
PH12015502216A1 (en) Compositions and methods for improving the health of aquatic animals
MX352324B (es) Vacunas multivalentes de nanovehiculos sinteticos.
MX2016008448A (es) Conjugados de var2csa-farmaco.
CL2015003479A1 (es) Métodos y composiciones de fermentación bacterial.
MY191539A (en) Streptococcal vaccine
EP3200831A4 (en) Vaccines having an antigen and interleukin-21 as an adjuvant
MY189495A (en) Hand, foot, and mouth vaccines and methods of manufacture and use thereof
NZ715459A (en) A hyperbarically-inactivated microorganism, immunogenic compositions comprising same and methods for producing same
EP3151858A4 (en) Antibody guided vaccines and methods of use for generation of rapid mature immune responses
WO2012170097A3 (en) Compositions and methods for inducing immune responses against bacteria in the genus staphylococcus
UY34702A (es) Composiciones y métodos agrícolas u hortícolas
PH12016501434A1 (en) Compositions for use in the treatment of allergic conditions
PE20190225A1 (es) Un metodo para reducir la contaminacion de huevo
EP3078677A4 (en) Antigen chimera, antigen combination, vaccine, method of preparing same, and kit thereof
TR201904585T4 (tr) Göz yorgunluğu ve rahatsızlığını bertaraf etmek ve hafifletmek için göz ferahlatıcı madde.
WO2013033092A3 (en) Streptococcus suis pilus antigens
EA201791437A1 (ru) Композиции микросфер c инкапсулированным в липиде газом и соответствующие способы

Legal Events

Date Code Title Description
FG Grant, registration